European Commission Approves Lynparza for BRCA-Mutated Metastatic Pancreatic Cancer

July 08, 2020

The European Commission has approved Lynparza (olaparib) for use in patients with germline BRCA-mutated (gBRCAm) metastatic pancreatic cancer within the European Union.

Can Using RNA Simplify Gene Therapy Development?

July 01, 2020

RNA is easier to manipulate than DNA but challenging to deliver to the right cells.

Navigating Uncharted Waters

July 01, 2020

Data and science must guide FDA in making pressure-filled COVID-19 vaccine and therapy approval decisions.

Plasma-Based Antibody Therapies Battle Against COVID-19

June 01, 2020

Therapies for early and late treatment and passive immunization of COVID-19 are needed and can be developed using antibodies from recovered patients.

Orgenesis to Acquire Tamir Biotechnology for Broad Spectrum Antiviral Platform

April 14, 2020

With the acquisition, Orgenesis will combine TamirBio’s ranpirnase antiviral platform with its Bioxome technology.

On Point: Biologics Drive Growth in Pre-Filled Syringes

April 01, 2020

As a result of the rising use and development of biological drugs, the biopharma industry is witnessing an increase in the adoption of prefilled syringes.

Seeking Early Answers to Formulation Questions

March 01, 2020

Contract service organizations can offer biopharma companies early insight into dangers that may hinder a drug’s later development.

MilliporeSigma and ReForm Collaborate on Excipient Commercialization

February 13, 2020

The companies have entered into a global licensing and collaboration agreement to commercialize ReForm excipients used in biotherapeutic formulations.

Fresh Thinking in Biologic Drug Formulation

February 01, 2020

Biologics raise unique formulation and development challenges, and industry is still on a learning curve to get the best out of these diverse and complex therapies.

Therapeutic Potential of Green, Synthesized Gold Nanoparticles

January 01, 2020

This study aims to use plant-leaf extract for the green synthesis of gold nanoparticles and to evaluate their antibacterial and antioxidant activity.